Medicus Pharma MDCX
NASDAQ MDCX
$0.16 +0.00 (+2.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

Medicus Pharma (MDCX) Research & Development (2024 - 2026)

Updated

Medicus Pharma (MDCX) recorded Research & Development of $4.91 million in Q2 2026, up 240.9% from $1.44 million a year earlier.

Analysis

Medicus Pharma (MDCX) Research & Development (2024 - 2026) Analysis & Trends

On a TTM basis, Medicus Pharma's Research & Development came in at $15.06 million as of Jun 30, 2026, up 180.3% year-over-year; for FY2025, it came in at $8.72 million, up 147.1% from FY2024.

  • Across earlier years, Research & Development came in at $3.53 million in FY2024 and $193,578 in FY2023.
  • Quarterly Research & Development has ranged from $321,377 in Q1 2024 to $8.72 million in Q3 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Medicus Pharma 9.03 Mn -33.15 Mn - 4.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.91 Mn
Sep 30, 2025 8.72 Mn
Jun 30, 2025 1.44 Mn
Mar 31, 2025 2.01 Mn
Dec 31, 2024 1.37 Mn
Sep 30, 2024 564,145.00
Jun 30, 2024 1.28 Mn
Mar 31, 2024 321,377.00
API Access

Medicus Pharma Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=MDCX&period=max&api_key=YOUR_API_KEY